Drag a card by its title · ⚙ to size, swap or remove

The company

MapLight Therapeutics, Inc.

MPLT · Nasdaq

Health CareBiotechnologyNot moving yet

MPLT stood above a rising 150-day average in 4 of the last 16 weekly readings, and has been out of that trend for the last 12 weeks. It is 65.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 12
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $241.2M
Insider sales, 12 months: $59.4M
Officials’ trades on record: 0
Institutions holding: 100 (+22)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 16 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months11

Sale orders, 12 months73

Buyers · sellers5 · 8

Who	Did	Shares	Traded
Christopher A. KroegerChief Executive Officer	sold	73,691at $8.08	15 Oct 2026filed 16 Oct 2026
Jonathan GillisCAO and Interim CFO	sold	10,167at $8.08	15 Oct 2026filed 16 Oct 2026
James Woodruff LillieChief Scientific Officer	sold	11,513at $8.08	15 Oct 2026filed 16 Oct 2026
Kristopher HansonGeneral Counsel	sold	9,020at $8.08	15 Oct 2026filed 16 Oct 2026
Erin Pennock FoffChief Medical Officer	sold	15,355at $8.08	15 Oct 2026filed 16 Oct 2026
Anatol KreitzerChief Discovery Officer	sold	12,248at $7.84	15 Oct 2026filed 16 Oct 2026
Kristopher HansonGeneral Counsel	sold	16,509at $11.67	16 Sep 2026filed 18 Sep 2026
Catalyst4, Inc.10% owner	bought	4,400,000at $11.38	14 Aug 2026filed 18 Aug 2026
Catalyst4, Inc.10% owner	bought	2,928,686at $11.38	14 Aug 2026filed 18 Aug 2026
James Woodruff LillieChief Scientific Officer	sold	22,082at $12.54	3 Aug 2026filed 4 Aug 2026
Catalyst4, Inc.10% owner	bought	1,000,000at $13.00	30 Jul 2026filed 30 Jul 2026
Catalyst4, Inc.10% owner	bought	3,000at $12.63	29 Jul 2026filed 30 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders100+22 on the quarter

New · exited35 · 12

Reported value$793.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
NOVO HOLDINGS A/Sunchanged · filed 14 Aug 2026	3,686,622$132.1M	00.0%
FCPM III SERVICES B.V.unchanged · filed 14 Aug 2026	3,226,400$115.6M	00.0%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026	1,948,312$69.8M	-46,561−2.3%
BlackRock, Inc.reduced · filed 7 Aug 2026	1,025,134$36.7M	-314,597−23.5%
Nan Fung Group Holdings Ltdunchanged · filed 13 Aug 2026	971,253$34.8M	00.0%
5AM Venture Management, LLCunchanged · filed 14 Aug 2026	950,011$34.0M	00.0%
Sanofiunchanged · filed 28 Jul 2026	912,041$32.7M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	852,150$30.5M	+513,034+151.3%
FMR LLCadded · filed 13 Aug 2026	823,556$29.5M	+619,055+302.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	784,150$28.1M	+64,330+8.9%